New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
about
Pyrazolopyridine Inhibitors of B-Raf V600E . Part 1: The Development of Selective, Orally Bioavailable, and Efficacious InhibitorsSurvivin delta Ex3 overexpression in thyroid malignanciesAssociation between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma.NF-kappaB p65 subunit mediates lipopolysaccharide-induced Na(+)/I(-) symporter gene expression by involving functional interaction with the paired domain transcription factor Pax8Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancerMolecular pathogenesis and mechanisms of thyroid cancermRNA expression in papillary and anaplastic thyroid carcinoma: molecular anatomy of a killing switchThe BRAFV600E mutation: what is it really orchestrating in thyroid cancer?Recent advances in molecular diagnosis of thyroid cancer.Standard and emerging therapies for metastatic differentiated thyroid cancer.Modeling thyroid cancer in the mouse.Association between single-nucleotide polymorphisms of BRAF and papillary thyroid carcinoma in a Chinese populationAssociation Between (18)F-FDG Avidity and the BRAF Mutation in Papillary Thyroid Carcinoma.Analysis of gene expression in a developmental context emphasizes distinct biological leitmotifs in human cancers.Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).Clinical implications of molecular markers in follicular cell-derived thyroid cancer.Anaplastic thyroid cancer: a comprehensive review of novel therapy.Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.Synthesis, biological evaluation and molecular docking of novel 5-phenyl-1H-pyrazol derivatives as potential BRAF(V600E) inhibitors.New Insights in Thyroid Cancer and p53 Family Proteins.siRNA targeted for NBS1 enhances heat sensitivity in human anaplastic thyroid carcinoma cells.Nucleophosmin delocalization in thyroid tumour cells.Role of serum cytokeratin 19 fragment (Cyfra 21.1) as a prognostic biomarker in patients with differentiated thyroid cancer.Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription.Thyroid follicular adenomas and carcinomas: molecular profiling provides evidence for a continuous evolution.Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes.Genetic Polymorphism Predisposing to Differentiated Thyroid Cancer: A Review of Major Findings of the Genome-Wide Association Studies.
P2860
Q27684109-B211BBA6-E959-4BFB-B96D-EFB7495F6787Q31166524-F1DE25EF-A67B-4005-B4DC-46B44F330F12Q33597740-0D806433-2384-48AA-A3F4-D28DB15D5C9CQ33637267-29F670D4-4F7F-4B8D-AFCB-82D18035CC5DQ33691759-2CF01A3C-B16D-48AA-82BE-4986031977EBQ33906375-6D08FA99-C49D-4EB5-969A-54DC8BA11C62Q34329018-0E43A10C-AD03-41D8-A9A9-17F1E053D3BCQ34463393-4F225FFB-6BE7-40FC-B6F7-29E678FA5F6CQ34781888-8D59EDCF-73DA-4D52-9AEE-86149FD296D5Q34985320-E408F87C-D5D4-451D-9016-26A86A15964BQ35583906-7975FB3A-6FD4-42C6-8C1D-6DD78EDECFF2Q36297044-37B146FD-4929-42FA-A8AF-B1EE10EABC83Q36515437-43307776-423D-4713-8992-C257C4A8B7B1Q36604985-5F9C9F77-89C7-4C33-B59B-CCFB3AB2F510Q36864745-BE86B292-41F0-4724-A224-006C9EEAF19AQ37270522-9ECE4913-7641-4195-9A88-1C99CEB28A8CQ37611825-2E182996-3962-42C4-BCAD-E18483039259Q37854708-1025E4D3-F1BA-46A6-BF18-A463E2DC80A8Q37988566-7B2BAE56-C4C6-4649-AD61-C5451288B720Q39110584-B512A4A5-C24D-425A-B667-C1938C8A05F6Q39387810-6784DE2B-EFC9-4749-BD63-BEB6EF39ECB3Q39557112-F5076D9B-1F3C-410B-8069-8CC0C95C0DEFQ39603964-6DEE000B-A086-44F1-9FE5-22A38554080EQ41260250-18C205F2-6771-420D-B3F5-B784106624B0Q51157814-E1CE44D6-86B4-409D-8290-BDF21BEE29C1Q54389591-7CD600BB-03AC-4689-A398-FD6158FC4246Q55004058-FB225A49-B47D-4CA8-9601-181C7D70E60BQ55078257-D68EBA3E-8CF0-46BB-9A13-959A8D883CDCQ55399312-E04FAA14-E9D0-4BA9-9625-9D549E87206F
P2860
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@en
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@nl
type
label
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@en
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@nl
prefLabel
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@en
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@nl
P356
P1476
New insights in thyroid follicular cell biology and its impact in thyroid cancer therapy.
@en
P304
P356
10.1677/ERC-07-0085
P577
2007-12-01T00:00:00Z